CPU-CHINA

October 21, 2023

CPU-CHINA # BI-BYE: Solution of Engineering Probiotics for Colorectal Cancer # Colorectal cancer (CRC) ranks as the third most common cancer worldwide.However, the treatment options for CRC are often expensive and have limited efficacy, causing severe adverse effects among patients.So there is an urgent need for improved treatment options for colorectal cancer.Fusobacterium nucleatum (Fn) is closely linked to the onset and progression of CRC, resulting in unfavorable prognoses.This year, CPU-CHINA has devised a therapy for Fn-mediated CRC. ...